J. Kaur, A Comprehensive Review on Metabolic Syndrome, Cardiology Research and Practice, vol.96, issue.8, p.943162, 2014.
DOI : 10.1001/archinte.163.17.2006

T. Han and M. Lean, A clinical perspective of obesity, metabolic syndrome and cardiovascular disease, JRSM Cardiovascular Disease, vol.242, 2016.
DOI : 10.1016/S0025-6196(11)60766-0

K. Srikanthan, A. Feyh, H. Visweshwar, J. Shapiro, and K. Sodhi, Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population, International Journal of Medical Sciences, vol.13, issue.1, pp.25-38, 2016.
DOI : 10.7150/ijms.13800

S. Grundy, Metabolic syndrome update, Trends in Cardiovascular Medicine, vol.26, issue.4, pp.364-73, 2016.
DOI : 10.1016/j.tcm.2015.10.004

D. Dallmeier, M. Larson, R. Vasan, J. Keaney, J. Fontes et al., Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study, Diabetology & Metabolic Syndrome, vol.4, issue.1, p.28, 2012.
DOI : 10.1016/j.metabol.2005.08.019

Z. Al?hamodi, M. Al?habori, A. Al?meeri, and R. Saif?ali, Association of adi? pokines, leptin/adiponectin ratio and C?reactive protein with obesity and type 2 diabetes mellitus, Diabetol Metab Syndr, vol.6, 2014.

J. Zhang, P. Kho, K. Ov, and C. S. Adiponectin, Adiponectin, Resistin and Leptin: Possible Markers of Metabolic Syndrome, Endocrinology & Metabolic Syndrome, vol.04, issue.04, 2016.
DOI : 10.4172/2161-1017.1000212

L. Rasmussen?torvik, C. Wassel, J. Ding, J. Carr, M. Cushman et al., Associations of body mass index and insulin resistance with leptin, adiponectin, and the leptin-to-adiponectin ratio across ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA), Annals of Epidemiology, vol.22, issue.10, pp.705-714, 2012.
DOI : 10.1016/j.annepidem.2012.07.011

P. López?jaramillo, D. Gómez?arbeláez, J. López?lópez, C. López?lópez, J. Martínez?ortega et al., The role of leptin/adi? ponectin ratio in metabolic syndrome and diabetes, Horm Mol Biol Clin Investig, vol.18, issue.1, pp.37-45, 2014.

G. Paz?filho, C. Mastronardi, C. Franco, K. Wang, M. Wong et al., Leptin: molecular mechanisms, systemic pro-inflammatory effects, and clinical implications, Arquivos Brasileiros de Endocrinologia & Metabologia, vol.62, issue.9, pp.597-607, 2012.
DOI : 10.1136/ard.62.10.952

N. Iikuni, Q. Lam, L. Lu, G. Matarese, L. Cava et al., Leptin and Inflammation, Current Immunology Reviews, vol.4, issue.2, pp.70-79, 2008.
DOI : 10.2174/157339508784325046

G. Fantuzzi, Adiponectin and inflammation: Consensus and controversy, Journal of Allergy and Clinical Immunology, vol.121, issue.2, pp.326-356, 2008.
DOI : 10.1016/j.jaci.2007.10.018

H. Mangge, G. Almer, M. Truschnig?wilders, A. Schmidt, R. Gasser et al., Inflammation, Adiponectin, Obesity and Cardiovascular Risk, Current Medicinal Chemistry, vol.17, issue.36, pp.4511-4531, 2010.
DOI : 10.2174/092986710794183006

K. Robinson, J. Prins, and B. Venkatesh, Clinical review: Adiponectin biology and its role in inflammation and critical illness, Critical Care, vol.15, issue.2, p.221, 2011.
DOI : 10.1007/s00424-008-0564-8

P. Lopez?jaramillo, SSA 04-3 LEPTIN/ADIPONECTIN IN CARDIOMETABOLIC DISEASE, Journal of Hypertension, vol.34, p.7, 2016.
DOI : 10.1097/01.hjh.0000499887.23096.ce

Q. Zhuo, Z. Wang, P. Fu, J. Piao, Y. Tian et al., Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities, Diabetes Research and Clinical Practice, vol.84, issue.1, pp.27-33, 2009.
DOI : 10.1016/j.diabres.2008.12.019

E. Falahi, K. Rad, A. Roosta, and S. , What is the best biomarker for metabolic syndrome diagnosis?, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol.9, issue.4, pp.366-72, 2015.
DOI : 10.1016/j.dsx.2013.06.014

J. Hughes, O. Dea, K. Piera, K. Barzi, F. Cass et al., Associations of serum adiponectin with markers of cardio-metabolic disease risk in Indigenous Australian adults with good health, diabetes and chronic kidney disease, Obesity Research & Clinical Practice, vol.10, issue.6, pp.659-72, 2016.
DOI : 10.1016/j.orcp.2015.11.008

N. Satoh, M. Naruse, T. Usui, T. Tagami, T. Suganami et al., Leptin-to-Adiponectin Ratio as a Potential Atherogenic Index in Obese Type 2 Diabetic Patients, Diabetes Care, vol.27, issue.10, pp.2488-90, 2004.
DOI : 10.2337/diacare.27.10.2488

A. Gauthier, S. Dubois, S. Bertrais, Y. Gallois, C. Aube et al., The Leptin to Adiponectin Ratio is a Marker of the Number of Metabolic Syndrome Criteria in French Adults, Journal of Metabolic Syndrome, vol.01, issue.01, pp.1-6, 2011.
DOI : 10.4172/2167-0943.1000101

N. Oda, S. Imamura, T. Fujita, Y. Uchida, K. Inagaki et al., The ratio of leptin to adiponectin can be used as an index of insulin resistance, Metabolism, vol.57, issue.2, pp.268-73, 2008.
DOI : 10.1016/j.metabol.2007.09.011

C. Ayina, J. Noubiap, E. Ngoa, L. Boudou, P. Gautier et al., Association of serum leptin and adiponectin with anthropo? morphic indices of obesity, blood lipids and insulin resistance in a sub? Saharan African population, Lipids Health Dis, vol.15, 2016.

D. Okorodudu, M. Jumean, V. Montori, A. Romero?corral, V. Somers et al., Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis, International Journal of Obesity, vol.85, issue.5, pp.791-800, 2010.
DOI : 10.1016/S0140-6736(07)61778-4

K. Alberti, R. Eckel, S. Grundy, P. Zimmet, J. Cleeman et al., Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity, Circulation, vol.120, issue.16, pp.1640-1645, 2009.
DOI : 10.1161/CIRCULATIONAHA.109.192644

V. Frankenberg, A. Nascimento, F. Gatelli, L. Nedel, B. Garcia et al., Major components of metabolic syndrome and adiponectin levels: a cross-sectional study, Diabetology & Metabolic Syndrome, vol.6, issue.1, p.26, 2014.
DOI : 10.2337/diacare.28.9.2181

K. Kotani and N. Sakane, Leptin:Adiponectin Ratio and Metabolic Syndrome in the General Japanese Population, The Korean Journal of Laboratory Medicine, vol.31, issue.3, pp.162-168, 2011.
DOI : 10.3343/kjlm.2011.31.3.162

S. Van-zyl, L. Van-der-merwe, F. Van-rooyen, G. Joubert, and C. Walsh, The relationship between obesity, leptin, adiponectin and the components of metabolic syndrome in urban African women, Free State, South Africa, South African Journal of Clinical Nutrition, vol.3, issue.3, pp.68-73, 2017.
DOI : 10.4102/phcfm.v4i1.346

W. Nour?eldine, C. Ghantous, K. Zibara, L. Dib, H. Issaa et al., Adiponectin Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Remodeling through Nitric Oxide and the RhoA/ROCK Pathway, Frontiers in Pharmacology, vol.114, issue.e109017, 2016.
DOI : 10.1042/CS20070347

H. Chou, L. Hsu, S. Wu, M. Teng, Y. Sun et al., Leptin?to?adiponec? tin ratio is related to low grade inflammation and insulin resistance inde? pendent of obesity in non?diabetic Taiwanese: a cross?sectional cohort study, Acta Cardiol Sin, vol.30, issue.3, pp.204-218, 2014.